Effective communication of drug safety information to patients and the public: a new look
- PMID: 12020171
- DOI: 10.2165/00002018-200225050-00002
Effective communication of drug safety information to patients and the public: a new look
Abstract
Recent parallel developments in the fields of medicine and the social sciences are providing us with new insights and resources that have the potential for improving the effectiveness of drug safety communication and decision-making. These developments include medicine's new look at patient safety with its emphasis on complex adaptive systems, education's new appreciation for learning as an internal change process and risk communication's evolving recognition that relevant knowledge may not be the exclusive property of 'experts'. Eight principles are drawn from this analysis: there cannot be a safer drug until there is a safer system;all stakeholders are equal partners and have an equal voice in all deliberations;paternalism must be eliminated;the expertise for determining acceptable benefit and risk is dispersed throughout society;patients and all stakeholders serve as both teachers and learners;all stakeholders are involved in the identification of their learning needs, processes and evaluation of outcomes;in a complex adaptive system all individual actions are interconnected and;patients must be involved in the continuous feedback and redesign of the evolving drug safety information system. The conclusion is that we are not asking the right questions; 'what information should we communicate?' and 'how do we communicate more effectively?' should be reframed to ask 'how do we provide an equal voice for patients with the other stakeholders in the determination and communication of benefit-risk information?' Some patients are not waiting. The International Alliance of Patient Organizations (IAPO), the Database of Individual Patient Experience (Dipex) and the Self-Help Group Clearinghouse are examples of international patient driven efforts to actively participate in their own care. The author suggests that the emerging discipline of inter-active management can contribute methodologies for creating citizenship models to generate the collective wisdom and translate it into action. A future research agenda calls for creating new models of public accountability that support these evolving systems of engaging the entire community in benefit-risk determination, communication and management.
Similar articles
-
Risk management frameworks for human health and environmental risks.J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608. J Toxicol Environ Health B Crit Rev. 2003. PMID: 14698953 Review.
-
Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders.Value Health. 2015 Jun;18(4):477-83. doi: 10.1016/j.jval.2014.12.015. Epub 2015 Feb 18. Value Health. 2015. PMID: 26091602
-
A research roadmap for complementary and alternative medicine - what we need to know by 2020.Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24. Forsch Komplementmed. 2014. PMID: 24851850
-
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.Mult Scler Relat Disord. 2018 Jan;19:153-160. doi: 10.1016/j.msard.2017.11.013. Epub 2017 Nov 21. Mult Scler Relat Disord. 2018. PMID: 29241142
-
[Risk/Benefit Communication: International Developments and Prospects for the Future].Yakugaku Zasshi. 2018;138(3):299-306. doi: 10.1248/yakushi.17-00185-1. Yakugaku Zasshi. 2018. PMID: 29503420 Review. Japanese.
Cited by
-
Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis.Drug Saf. 2022 Oct;45(10):1083-1098. doi: 10.1007/s40264-022-01222-y. Epub 2022 Aug 25. Drug Saf. 2022. PMID: 36008634 Free PMC article. Review.
-
Problem-based training improves recognition of patient hazards by advanced medical students during chart review: a randomized controlled crossover study.PLoS One. 2014 Feb 20;9(2):e89198. doi: 10.1371/journal.pone.0089198. eCollection 2014. PLoS One. 2014. PMID: 24586591 Free PMC article. Clinical Trial.
-
Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.Drug Saf. 2006;29(8):657-73. doi: 10.2165/00002018-200629080-00003. Drug Saf. 2006. PMID: 16872240 Review.
-
Survey of medication knowledge and behaviors among college students in Taiwan.Am J Pharm Educ. 2006 Apr 15;70(2):30. doi: 10.5688/aj700230. Am J Pharm Educ. 2006. PMID: 17149410 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources